Press Room

Webinar Series: All you need to know about Continuous Tableting

Start
Wednesday, May 29, 2024 - 16:00
End
Wednesday, July 10, 2024 - 17:00
Location: online
Webinar series - all you need to know about continuous tableting | Hovione

Hovione presents the most comprehensive three-part webinar series on "Opportunities, Challenges and Success in Implementing Continuous Tableting – From R&D to Commercial Manufacturing".

Over the course of this series, Hovione experts and invited speakers from Merck Sharpe & Dohme, Vertex Pharmaceuticals and GEA Group will guide you through the journey of continuous manufacturing (CM) of oral solid dosage forms, also known as continuous tableting (CT), aiming to highlight key opportunities, successes, and challenges with continuous tableting. 

The content of the webinars will cover the role of CM along a wide breadth of the CMC journey, starting with lean and model-based development and concluding with commercial implementation of continuous tableting processes. 

Each session in the series will be presented as a joint talk with participants from innovators like Merck and Vertex Pharmaceuticals, and Hovione, highlighting experiences from each organization and the many advantages of a partnership-based approach. The webinar series will conclude with a final joint talk between GEA Group and Hovione announcing exciting joint innovations in the CT equipment space along with the latest advances in technology simplification.

Featured experts will be available to answer audience questions during a live Q&A after each talk.

SESSION 1 - On-demand

Lean Process Development for Continuous Tableting: Foundations of a Hybrid Approach

The recording is now available.

SESSION 2 - On-demand

Insights from Commercial Implementation of Continuous Tableting: Successes and Challenges of a Partnership-Oriented Approach

Thursday, June 20
11:00 am EDT  |  4:00 pm GMT  |  ​5:00 pm CEST

SESSION 3 - On-demand

Simplification of Continuous Tableting for Accelerated Product Development and Lifecycle Flexibility

Wednesday, July 10
11:00 am EDT  |  4:00 pm GMT  |  5:00 pm CEST

 

 

 

 

 

 

 

 

 

 

 

Find out today if continuous tableting is right for your product. 

The Future is Continuous.

 

 

Also in the Press Room

See All

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024